Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization
Gut and Liver · 15.11.2026 · 20 (6) · 1039-1054
DOI: 10.5009/gnl250253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gut and Liver, online erschienen am 07.05.2026. Verfasst von Xiangpang Xie und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatic-Biliary-Pancreatic Surgery, Cangnan County People's Hospital, Cangnan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Efferocytosis, Chemoembolization, Therapeutic. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatic-Biliary-Pancreatic Surgery, Cangnan County People's Hospital, Cangnan, China.
- Department of Vascular Interventional Surgery, The Third Affiliated Hospital of Wenzhou Medical University, Ruian, China.
ORCID-Profile: Xiangpang Xie, Bingru Zheng
Zitieren
APA
Xie, X., & Zheng, B. (2026). Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization. Gut and Liver, 20(6), 1039-1054. https://doi.org/10.5009/gnl250253
Vancouver
Xie X, Zheng B. Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization. Gut and Liver. 2026;20(6):1039-1054. doi:10.5009/gnl250253
BibTeX
@article{Xie2026,
author = {Xie, Xiangpang and Zheng, Bingru},
title = {Novel Efferocytosis-Related Prognostic Signature for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization},
journal = {Gut and Liver},
year = {2026},
volume = {20},
number = {6},
pages = {1039--1054},
doi = {10.5009/gnl250253}
}
EUVIMED